… timely, confident, and data-driven treatment decisions when every moment counts … phase 3 trial supported the FDA approval of nivolumab plus ipilimumab in patients … Hersey, vice president of Precision Medicine, Bioanalytical and Translational Sciences at …

… New Approach to Treatment for Peritoneal Mesothelioma The medical team approached … patient received nivolumab (Opdivo®) and ipilimumab (Yervoy®) to attack the tumor … top resources on nearby doctors, treatment options, clinical trials, support groups, and …

… Back to Healio The FDA has approved the Idylla … who may benefit from treatment with nivolumab (Opdivo, … with ipilimumab (Yervoy, Bristol Myers Squibb). The FDA has … treatment decisions when every moment counts,” Michael Korn, MD, Biocartis’ chief medical …

… of ipilimumab and nivolumab as frontline treatment … investigations that inform FDA approvals, clinical … thereby accelerating personalized medicine. Collectively, the … Trials in OncologyASCO Annual Meeting 2025cancer treatment advancementsclinical trial …

… president of Precision Medicine, Bioanalytical and … , open-label trial randomly assigned patients … Treatment Paradigm? Notably, nivolumab plus ipilimumab was FDA … fda.gov/drugs/;resources-information-approved-drugs/fda-approves-nivolumab-ipilimumab …

Panelists discuss how treatment selection for a typical intermediate- … carcinoma (RCC) involves choosing between ipilimumab plus nivolumab for long-term …

… PMA) from the FDA for a cartridge-based … treatment with OPDIVO® (nivolumab) alone, or in combination with YERVOY® (ipilimumab … ), as established in the CheckMate-8HW trial ( … Vice President, Precision Medicine, Bioanalytical and Translational …

… next year. Panmure reckons the trial is likely to recruit more … Myers Squibb’s nivolumab and ipilimumab to iSCIB1+, produced an 80 … off-the-shelf cancer vaccine, is in trials for several solid tumours …

… ipilimumab) before surgery. After surgery, doctors gave Opdivo again. The trial … detection could let doctors adjust treatment sooner, potentially improving … survival and quality of life. Georgetown University Medical …

… treatment from 12 months of injections and pills … along with the FDA-approved medications acamprosate, naltrexone and … approved—pembrolizumab, nivolumab, ipilimumab and the combinations … drug to move the needle in advanced HCC.16 The REFLECT trial …